Paper Details

  1. Home
  2. Paper Details

Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper.

Author: CianciVittoria, Di BonaventuraCarlo, Di GennaroGiancarlo, GalimbertiCarlo Andrea, GuerriniRenzo, La NeveAngela, MecarelliOriano, PeruccaEmilio, PietrafusaNicola, SpecchioNicola, VigevanoFederico, VillaniFlavio

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Cenobamate, a new antiseizure medication (ASM), has been recently approved for the adjunctive treatment of focal-onset seizures in adults with epilepsy. This study provides an overview of the regulatory approval process and the potential role of cenobamate in epilepsy management.
Paper Details　
Original Abstract of the Article :
Cenobamate is a new antiseizure medication (ASM) recently introduced in the USA for the treatment of adults with focal-onset seizures. In March 2021, the European Commission authorized its use for the adjunctive treatment of focal-onset seizures with or without secondary generalization (focal seizur...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/14737175.2023.2171291

データ提供：米国国立医学図書館（NLM）

Cenobamate: A New Hope for Focal Epilepsy?

Navigating the complex world of epilepsy is like traversing a vast and often unpredictable desert. This research explores a new medication, cenobamate, for the treatment of focal epilepsy, a condition characterized by seizures affecting specific regions of the brain. The study evaluates the effectiveness of cenobamate as an adjunctive treatment, meaning it's used in combination with other antiseizure medications. The authors provide a thorough analysis of the drug's potential benefits, considering its safety and efficacy.

Cenobamate: A Potential New Ally in Epilepsy Treatment

The research indicates that cenobamate holds promise as a valuable tool for managing focal epilepsy. It could help individuals with epilepsy achieve better seizure control, potentially leading to a more fulfilling and independent life. Like a traveler finding a cool spring in the desert, this new treatment could bring relief and hope to many.

Living with Epilepsy: Embracing Knowledge and Support

Epilepsy can be a challenging condition, but understanding its complexities and exploring available treatment options is crucial. This study offers a glimmer of hope for those struggling with focal epilepsy, emphasizing the importance of seeking medical guidance and staying informed about the latest advancements.

Dr.Camel's Conclusion

This study sheds light on a promising new treatment option for focal epilepsy, offering a potential oasis in the desert of this complex condition. It emphasizes the importance of ongoing research and collaboration in the pursuit of more effective therapies to improve the lives of those living with epilepsy.

Date :
  1. Date Completed 2023-02-01
  2. Date Revised 2023-02-10
Further Info :

Pubmed ID

36662573

DOI: Digital Object Identifier

10.1080/14737175.2023.2171291

Related Literature

Article Analysis
・Effects of cenobamate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.